You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

List of Excipients in API olmesartan medoxomil


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing olmesartan medoxomil

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Cosette Pharmaceuticals Inc BENICAR olmesartan medoxomil 0713-0860 CELLULOSE, MICROCRYSTALLINE
Cosette Pharmaceuticals Inc BENICAR olmesartan medoxomil 0713-0860 FERRIC OXIDE YELLOW
Cosette Pharmaceuticals Inc BENICAR olmesartan medoxomil 0713-0860 HYDROXYPROPYL CELLULOSE
Cosette Pharmaceuticals Inc BENICAR olmesartan medoxomil 0713-0860 HYPROMELLOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing olmesartan medoxomil

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc olmesartan medoxomil 0378-7012 HYDROXYPROPYL CELLULOSE
Mylan Pharmaceuticals Inc olmesartan medoxomil 0378-7012 HYPROMELLOSE
Mylan Pharmaceuticals Inc olmesartan medoxomil 0378-7012 LACTOSE MONOHYDRATE
Mylan Pharmaceuticals Inc olmesartan medoxomil 0378-7012 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for olmesartan medoxomil

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77891

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

olmesartan medoxomil drug variants containing FERRIC OXIDE RED

Company Ingredient NDC
Macleods Pharmaceuticals Limited olmesartan medoxomil amlodipine and hydrochlorothiazide 33342-243
Slate Run Pharmaceuticals LLC olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide 70436-014
Accord Healthcare Inc olmesartan medoxomil and hydrochlorothiazide 16729-366
Camber Pharmaceuticals Inc olmesartan medoxomil and hydrochlorothiazide 31722-886
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

olmesartan medoxomil drug variants containing FERROSOFERRIC OXIDE

Company Ingredient NDC
Macleods Pharmaceuticals Limited olmesartan medoxomil amlodipine and hydrochlorothiazide 33342-243
Slate Run Pharmaceuticals LLC olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide 70436-014
Solco Healthcare US LLC olmesartan medoxomil and hydrochlorothiazide 43547-391
A-S Medication Solutions olmesartan medoxomil and hydrochlorothiazide 50090-6836
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: HEMATITE

Excipient focus: HYDROGENATED CASTOR OIL

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

olmesartan medoxomil drug variants containing HYPROMELLOSE 2208

Company Ingredient NDC
Par Pharmaceutical Inc olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 49884-786
Bryant Ranch Prepack olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 63629-2238
Bryant Ranch Prepack olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 63629-2239
Bryant Ranch Prepack olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 63629-2241
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

olmesartan medoxomil drug variants not containing LACTOSE MONOHYDRATE

Company Ingredient NDC
Bryant Ranch Prepack olmesartan medoxomil 71335-0999
Cosette Pharmaceuticals Inc olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 0713-0874
Par Pharmaceutical Inc olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 49884-786
Endo USA Inc olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 49884-790
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: PEG-10 .BETA.-SITOSTERYL ETHER

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1000

olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 1000

Company Ingredient NDC
Par Pharmaceutical Inc olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 49884-786
Endo USA Inc olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 49884-790
Bryant Ranch Prepack olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 63629-2238
Bryant Ranch Prepack olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 63629-2239
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYSORBATE 20

olmesartan medoxomil drug variants containing POLYSORBATE 20

Company Ingredient NDC
Par Pharmaceutical Inc olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 49884-786
Bryant Ranch Prepack olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 63629-2238
Bryant Ranch Prepack olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 63629-2239
Bryant Ranch Prepack olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 63629-2241
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE K30

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

olmesartan medoxomil drug variants not containing TITANIUM DIOXIDE

Company Ingredient NDC
Mylan Pharmaceuticals Inc olmesartan medoxomil 0378-7012
Cosette Pharmaceuticals Inc olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 0713-0874
Daiichi Sankyo Inc olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 65597-114
A-S Medication Solutions olmesartan medoxomil and hydrochlorothiazide 50090-7478
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links